Evidence map›Paper›PMID 36175975›Full record

ArticleJournal of experimental & clinical cancer research : CR2022

Correction: CELLFOOD™ induces apoptosis in human mesothelioma and colorectal cancer cells by modulating p53, c-myc and pAkt signaling pathways.

Barbara Nuvoli, Raffaela Santoro, Simona Catalani, Serafina Battistelli, Serena Benedetti, Franco Canestrari, Rossella Galati

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Barbara NuvoliMolecular Medicine Area, Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Raffaela SantoroMolecular Medicine Area, Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Simona CatalaniDepartment of Biomolecular Sciences, Section of Clinical Biochemistry and Cellular Biology, University of Urbino "Carlo Bo", Via Ubaldini 7, 61029, Urbino, PU, Italy.
Serafina BattistelliDepartment of Biomolecular Sciences, Section of Clinical Biochemistry and Cellular Biology, University of Urbino "Carlo Bo", Via Ubaldini 7, 61029, Urbino, PU, Italy.
Serena BenedettiDepartment of Biomolecular Sciences, Section of Clinical Biochemistry and Cellular Biology, University of Urbino "Carlo Bo", Via Ubaldini 7, 61029, Urbino, PU, Italy.
Franco CanestrariDepartment of Biomolecular Sciences, Section of Clinical Biochemistry and Cellular Biology, University of Urbino "Carlo Bo", Via Ubaldini 7, 61029, Urbino, PU, Italy.
Rossella GalatiMolecular Medicine Area, Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy. galati@ifo.it.
University of Urbino · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36175975
PMCPMC9524089
OpenAlexW4297988779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.